IAP
Indie Asset Partners’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,468
| Closed | -$308K | – | 68 |
|
2025
Q1 | $308K | Sell |
1,468
-639
| -30% | -$134K | 0.27% | 61 |
|
2024
Q4 | $374K | Buy |
2,107
+8
| +0.4% | +$1.42K | 0.29% | 55 |
|
2024
Q3 | $414K | Sell |
2,099
-46
| -2% | -$9.08K | 0.31% | 55 |
|
2024
Q2 | $368K | Sell |
2,145
-891
| -29% | -$153K | 0.29% | 56 |
|
2024
Q1 | $553K | Buy |
3,036
+15
| +0.5% | +$2.73K | 0.49% | 36 |
|
2023
Q4 | $468K | Buy |
3,021
+6
| +0.2% | +$930 | 0.42% | 33 |
|
2023
Q3 | $449K | Sell |
3,015
-24
| -0.8% | -$3.58K | 0.45% | 36 |
|
2023
Q2 | $409K | Sell |
3,039
-47
| -2% | -$6.33K | 0.45% | 38 |
|
2023
Q1 | $492K | Sell |
3,086
-430
| -12% | -$68.5K | 0.57% | 31 |
|
2022
Q4 | $568K | Sell |
3,516
-224
| -6% | -$36.2K | 0.62% | 32 |
|
2022
Q3 | $502K | Sell |
3,740
-165
| -4% | -$22.1K | 0.51% | 35 |
|
2022
Q2 | $598K | Sell |
3,905
-27
| -0.7% | -$4.14K | 0.53% | 33 |
|
2022
Q1 | $637K | Buy |
3,932
+123
| +3% | +$19.9K | 0.48% | 34 |
|
2021
Q4 | $516K | Sell |
3,809
-510
| -12% | -$69.1K | 0.37% | 46 |
|
2021
Q3 | $466K | Buy |
4,319
+675
| +19% | +$72.8K | 0.38% | 56 |
|
2021
Q2 | $410K | Buy |
3,644
+175
| +5% | +$19.7K | 0.33% | 63 |
|
2021
Q1 | $375K | Buy |
3,469
+690
| +25% | +$74.6K | 0.43% | 67 |
|
2020
Q4 | $298K | Sell |
2,779
-2,462
| -47% | -$264K | 0.35% | 71 |
|
2020
Q3 | $459K | Sell |
5,241
-50
| -0.9% | -$4.38K | 0.57% | 48 |
|
2020
Q2 | $489K | Buy |
5,291
+73
| +1% | +$6.75K | 0.61% | 43 |
|
2020
Q1 | $398K | Sell |
5,218
-794
| -13% | -$60.6K | 0.5% | 43 |
|
2019
Q4 | $532K | Buy |
+6,012
| New | +$532K | 0.57% | 41 |
|